Dr. Shah on Indications of Early-Onset CRC

Manish A. Shah, MD
Published: Wednesday, Apr 05, 2017



Manish A. Shah, MD, director of gastrointestinal oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, discusses indications of early-onset colorectal cancer (CRC).

Early-onset CRC is rising in incidence, which was confirmed on the most recent analysis, states Shah. SEER data, Risk Factor Analysis data, and available genomic data from The Cancer Genome Atlas (TCGA), were evaluated to determine if early-onset CRC is different to traditional CRC.

The results demonstrate that early-onset CRC is more prevalent in left-sided tumors. There is something specific about the biology of the left colon that is causing this increase, explains Shah.
 
SELECTED
LANGUAGE


Manish A. Shah, MD, director of gastrointestinal oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, discusses indications of early-onset colorectal cancer (CRC).

Early-onset CRC is rising in incidence, which was confirmed on the most recent analysis, states Shah. SEER data, Risk Factor Analysis data, and available genomic data from The Cancer Genome Atlas (TCGA), were evaluated to determine if early-onset CRC is different to traditional CRC.

The results demonstrate that early-onset CRC is more prevalent in left-sided tumors. There is something specific about the biology of the left colon that is causing this increase, explains Shah.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication
x